CompletedNot Applicable

CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction

Netherlands312 participantsStarted 2001-08

Plain-language summary

The purpose of this study is to assess the incidence of tachy- and bradyarrhythmic episodes in patients with acute myocardial infarction with depressed ventricular function and to determine the predictive value of several invasive and non-invasive risk markers for life-threatening arrhythmia

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Acute myocardial infarction (\< 21 days) * Ejection fraction \<= 40 % or wall motion index \<= 1.3 Exclusion Criteria: * Implantable loop recorder can't be implanted within 3 weeks after MI * NYHA class IV * Planned or previous ICD implantation * Planned CABG * Severe valvular disease * Pregnancy * Life expectancy \< 1 year for non-cardiac cause

What they're measuring

ECG-documented Ventricular Fibrillation or Symptomatic Sustained Ventricular Tachycardia (VT)

Timeframe: 2 year

Trial details

NCT IDNCT00145119

SponsorMedtronic Cardiac Rhythm and Heart Failure

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2007-05

Results submitted2013-12-02

View on ClinicalTrials.gov More Acute Myocardial Infarction trials